Evidence map›Paper›PMID 9566590›Full record

ArticleNeurochemical research1998

Activation of transcription factor AP-1 by extracellular ATP in PC12 cells.

Y Chen, A Y Sun

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Purinergic signalling and cancer.Purinergic signalling · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Y ChenDept. of Pharmacology, University of Missouri, Columbia 65212, USA.
A Y Sun
University of Missouri · US

Funding

ALCOHOL-MEMBRANE INTERACTION ON THE BRAIN: AGING EFFECTR01AA002054 · NIAAA · UNIVERSITY OF MISSOURI-COLUMBIA · PI SUN, ALBERT Y · 1985 to 1997
–
NIAAA NIH HHS R01 AA02054
6 · The paper itself

Abstract

We have previously shown that extracellular ATP caused cell death in PC12 cells through activation of its receptors. Oxidative stress has been implicated as a mechanism of cell death caused by extracellular ATP. In the present study we examined the possible signal transduction cascades leading to cell death by extracellular ATP. We found, using the electrophoretic mobility shift assay, that transcription factor AP-1 DNA binding activity was stimulated by extracellular ATP. Northern blot analysis showed that mRNA levels of c-fos, c-jun were elevated after treatment with ATP. The stimulation was receptor mediated, since it was blocked by the ATP receptor antagonist, suramin. The stimulated AP-1 binding was also blocked by the antioxidant N-acetyl-L-cysteine, indicating that reactive oxygen species generated following ATP stimulation were involved in the induction of AP-1 activity. It appears that both translational and posttranslational events contributed to the increased AP-1 DNA binding since cyclohexamide (a protein synthesis inhibitor), genistein (tyrosine kinase inhibitor) and staurosporine (PKC inhibitor) each partially blocked the AP-1 activation. Changes in AP-1 DNA binding activity may modulate expression of target genes involved in cell death pathways.

Indexed as

AcetylcysteineAdenosine TriphosphateAnimalsCell DeathEnzyme InhibitorsGenes, fosGenes, junOxidative StressPC12 CellsPhosphoprotein PhosphatasesProtein KinasesProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junPurinergic P2 Receptor AntagonistsRatsRNA, MessengerAcetylcysteineAdenosine TriphosphateEnzyme InhibitorsPhosphoprotein PhosphatasesProtein KinasesProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junPurinergic P2 Receptor AntagonistsRNA, MessengerSuraminTranscription Factor AP-1

Identifiers

PMID9566590
OpenAlexW125175355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.